We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CPR:MILDavide Campari-Milano N.V. Analysis

Data as of 2026-08-26 - not real-time

€5.90

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Davide Campari-Milano N.V. is neutral at €5.90, with no clear ordering between short and long averages. It has gained 6.4% over the past 30 days. Relative strength is 59.0 — neutral — and the MACD signal is bearish. The recent range runs from support at €5.70 up to resistance at €6.39.
The shares look fair at 25.7 times earnings, though no sector average was available for comparison. Analyst price targets sit 19.1% above the current price. The 1.67% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 22.5%, a beta of -0.01 and a maximum drawdown of 20.8%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.

Top Market Events

Davide Campari-Milano N.V. reported its latest earnings on May 6, 2026, drawing attention to revenueDavide Campari-Milano N.V. reported higher sales and profitability for Q1 2026, supported by strongAs spirits demand shifts toward premium brands amid economic uncertainty, Campari's iconic portfolio

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 5.89
  • MACD momentum is negative
  • 30-day price change of +6.4%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 5.89
  • Analyst targets imply +19.1% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +19.1% versus the current price
  • Revenue contracting at -1.0%
  • P/E ratio of 25.7

Key Metrics & Analysis

Financial Health

Revenue Growth-1.00%
Profit Margin8.87%
P/E Ratio25.7
ROE6.68%
ROA4.21%
Debt/Equity70.27
P/B Ratio1.8
Op. Cash Flow€556.6M
Free Cash Flow€172.1M

Technical Analysis

TrendNeutral
RSI59.0
Support€5.70
Resistance€6.39
MA 20€5.91
MA 50€5.69
MA 200€5.89
MACDBearish
VolumeDecreasing
Fear & Greed Index93.84

Valuation

Fair Value€0.09
Target Price€7.03
Upside/Downside19.09%
GradeFair
TypeBlend
Dividend Yield1.67%

Risk Assessment

Beta-0.01
Volatility22.47%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.